This tool gives an educational first-dose estimate for vancomycin from weight and creatinine clearance, targeting an AUC of 400–600 mg·h/L. It is a starting point only and does not replace Bayesian or two-level therapeutic drug monitoring (TDM), which remains essential for safe vancomycin therapy.
Why AUC-Guided Dosing
Vancomycin’s effectiveness against MRSA tracks with its total exposure — the area under the concentration–time curve (AUC) over a 24-hour period, relative to the organism’s MIC. The 2020 consensus guideline targets an AUC of 400–600 mg·h/L and moves away from the older practice of chasing high troughs (15–20 mg/L), which exposed patients to more kidney injury for no added benefit. Because vancomycin is cleared renally, the rate at which a patient eliminates it — captured by creatinine clearance — sets how much is needed to hit that exposure.
The Starting Components
- Loading dose: about 25–30 mg/kg of actual body weight, given once to reach therapeutic levels quickly. It is independent of kidney function because it fills the body’s volume of distribution rather than replacing what is cleared.
- Maintenance dose: about 15 mg/kg per dose, with the interval lengthening as creatinine clearance falls — every 8–12 hours in good kidney function, stretching to every 24 hours or longer in marked impairment.
Worked Example
Consider an 80 kg patient with a creatinine clearance of about 90 mL/min. A loading dose at 25 mg/kg is 25 × 80 = 2000 mg. Maintenance at 15 mg/kg is 15 × 80 = 1200 mg, and with near-normal clearance that would typically be given about every 12 hours as a first estimate. These figures are then confirmed and adjusted by measured levels — never assumed correct on the estimate alone.
How the Interval Tracks Creatinine Clearance
| Creatinine clearance | Typical starting interval |
|---|---|
| > 90 mL/min | Every 8–12 hours |
| 50 – 90 mL/min | Every 12 hours |
| 20 – 49 mL/min | Every 24 hours |
| < 20 mL/min | Extended interval, level-guided |
These intervals are first-dose orientation only; the actual schedule is set and revised by measured vancomycin levels.
Loading vs Maintenance: Two Different Jobs
It helps to see the loading and maintenance doses as solving different problems. The loading dose exists to fill the body’s volume of distribution quickly, so the drug reaches a therapeutic concentration in hours rather than days. Because it is about volume, not clearance, it is given on body weight and is the same whether the kidneys are healthy or failing — a patient in kidney failure still needs a full loading dose to get to target promptly. The maintenance dose, by contrast, replaces what the kidneys remove between doses, so it must track creatinine clearance: as clearance falls, the same dose is spaced further apart to avoid accumulation. Confusing the two — withholding a loading dose in renal impairment, or failing to lengthen the maintenance interval — is a common and avoidable error.
How the Estimate Is Refined by Levels
This calculator produces a first guess; real therapy then closes the loop with measurement. Two approaches dominate. Bayesian software takes one or two early levels and the patient’s characteristics and projects the full 24-hour AUC, allowing a dose adjustment after a single check. Alternatively, two timed levels — a peak and a trough within one dosing interval — let the AUC be calculated directly. Either way, the measured exposure is compared against the 400–600 mg·h/L target and the dose or interval is nudged up or down. Kidney function is rechecked through therapy, because vancomycin clearance can change quickly in acute illness, and a regimen that was correct on day one can drift out of range by day three. The estimate gets the patient close; monitoring keeps them in the window.
What AUC of 400–600 Represents
The target window is a balance. Below an AUC of about 400 mg·h/L (against a typical MIC of 1), vancomycin is less likely to clear a serious MRSA infection. Above about 600 mg·h/L, the risk of acute kidney injury climbs without added benefit. Aiming for the 400–600 band — confirmed by measured levels — keeps the patient in the zone where the drug is both effective and as safe as it reasonably can be. This is why modern practice tracks the full 24-hour exposure rather than a single trough level: two patients with the same trough can have quite different total exposures, and it is the exposure that drives both cure and harm.
A Second Worked Example
Consider a 60 kg patient with a creatinine clearance of about 35 mL/min. The loading dose at 25 mg/kg is 25 × 60 = 1500 mg, unchanged by the reduced clearance. The maintenance dose at 15 mg/kg is 15 × 60 = 900 mg, but with clearance in the 20–49 mL/min band it would typically start at every 24 hours rather than every 12 — the lengthened interval is how the regimen adapts to slower elimination. Measured levels then confirm whether that interval holds the AUC in range.
Limitations and Cautions
- This is an educational first-dose estimate, not a substitute for therapeutic drug monitoring. Confirm exposure with Bayesian software or two timed levels.
- Estimated creatinine clearance is least reliable in unstable kidney function, where it lags behind true clearance and can mislead dosing.
- Obesity, critical illness, dialysis, and rapidly changing renal function all alter vancomycin handling beyond what a simple estimate captures.
- Monitor kidney function and vancomycin levels throughout therapy; AUC above 600 mg·h/L raises the risk of nephrotoxicity.
See vancomycin renal dosing for the threshold table and the renal drug dosing hub for other agents.